The Contribution of the Skin Microbiome to Psoriasis Pathogenesis and Its Implications for Therapeutic Strategies
- PMID: 39459406
- PMCID: PMC11509136
- DOI: 10.3390/medicina60101619
The Contribution of the Skin Microbiome to Psoriasis Pathogenesis and Its Implications for Therapeutic Strategies
Abstract
Psoriasis is a common chronic inflammatory skin disease, associated with significant morbidity and a considerable negative impact on the patients' quality of life. The complex pathogenesis of psoriasis is still incompletely understood. Genetic predisposition, environmental factors like smoking, alcohol consumption, psychological stress, consumption of certain drugs, and mechanical trauma, as well as specific immune dysfunctions, contribute to the onset of the disease. Mounting evidence indicate that skin dysbiosis plays a significant role in the development and exacerbation of psoriasis through loss of immune tolerance to commensal skin flora, an altered balance between Tregs and effector cells, and an excessive Th1 and Th17 polarization. While the implications of skin dysbiosis in psoriasis pathogenesis are only starting to be revealed, the progress in the characterization of the skin microbiome changes in psoriasis patients has opened a whole new avenue of research focusing on the modulation of the skin microbiome as an adjuvant treatment for psoriasis and as part of a long-term plan to prevent disease flares. The skin microbiome may also represent a valuable predictive marker of treatment response and may aid in the selection of the optimal personalized treatment. We present the current knowledge on the skin microbiome changes in psoriasis and the results of the studies that investigated the efficacy of the different skin microbiome modulation strategies in the management of psoriasis, and discuss the complex interaction between the host and skin commensal flora.
Keywords: chronic inflammatory skin disease; prebiotics; probiotics; psoriasis; skin microbiome.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Comparative Analysis of the Cutaneous Microbiome in Psoriasis Patients and Healthy Individuals-Insights into Microbial Dysbiosis: Final Results.Int J Mol Sci. 2024 Oct 1;25(19):10583. doi: 10.3390/ijms251910583. Int J Mol Sci. 2024. PMID: 39408916 Free PMC article.
-
The role of the microbiome in psoriasis: moving from disease description to treatment selection?Br J Dermatol. 2018 May;178(5):1020-1027. doi: 10.1111/bjd.16081. Epub 2018 Mar 6. Br J Dermatol. 2018. PMID: 29071712 Review.
-
Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis.Int J Mol Sci. 2021 Apr 13;22(8):3998. doi: 10.3390/ijms22083998. Int J Mol Sci. 2021. PMID: 33924414 Free PMC article. Review.
-
Bacterial Dysbiosis and Translocation in Psoriasis Vulgaris.Front Cell Infect Microbiol. 2019 Feb 4;9:7. doi: 10.3389/fcimb.2019.00007. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 30778377 Free PMC article. Review.
-
Psoriasis: Interplay between dysbiosis and host immune system.Autoimmun Rev. 2022 Nov;21(11):103169. doi: 10.1016/j.autrev.2022.103169. Epub 2022 Aug 12. Autoimmun Rev. 2022. PMID: 35964945 Review.
References
-
- Parisi R., Symmons D.P., Griffiths C.E., Ashcroft D.M. Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J. Investig. Dermatol. 2013;133:377–385. doi: 10.1038/jid.2012.339. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical